Description

MOXIFINITY-625 Tablets contain a combination of Amoxycillin 500 mg and Clavulanate 125 mg, formulated to provide broad-spectrum antibacterial coverage against a wide range of bacterial infections, including beta-lactamase–producing organisms. Amoxycillin, a penicillin-class antibiotic, inhibits bacterial cell wall synthesis, while Clavulanate protects Amoxycillin from enzymatic degradation, thereby enhancing its antibacterial effectiveness.

This combination is commonly prescribed for respiratory tract infections, ear, nose and throat infections, urinary tract infections, skin and soft tissue infections, and dental infections. MOXIFINITY-625 Tablets offer reliable infection control, faster symptom relief, and improved treatment outcomes when used as directed.

Key Highlights:

• Contains Amoxycillin 500 mg + Clavulanate 125 mg

• Broad-spectrum antibacterial action

• Effective against beta-lactamase–producing bacteria

• Used in respiratory, ENT, UTI, skin, and dental infections

• Enhances antibacterial efficacy and treatment success

• Suitable for outpatient antibiotic therapy

• To be used under medical supervision

Dosage and duration should be followed strictly as prescribed by the physician to ensure safe and effective treatment.

If you want Monopoly PCD Franchise In Panchkula then please contact us.